October 11, 2021
  • The CMS released new data showing that nearly four times as many Medicare Advantage (MA) plans scored the highest quality rating possible for 2022 as compared with the year before. Seventy-four MA plans with prescription drug coverage earned five out of five stars, up from 21 in 2021, and 68 percent earned four stars or higher, up from just 49 percent the year prior. In 2022, 90 percent of Advantage members will be in plans with four stars or higher, compared with just 77 percent for 2021. Those weighted enrollment figures are subject to change as CMS reviews the data. (Press release here; Articles here and here)